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A B S T R A C T
Background: The epidemiology of acute myocardial infarction with ST-segment elevation (STEMI) has been 
modified in recent years, focusing on young people. Our goal was compare the clinical profile, laboratory, 
angiographic, and 30-day clinical outcomes of patients ≤ 40 years with those > 40 years undergoing 
primary percutaneous coronary intervention (pPCI).
Methods: Prospective cohort study of consecutive patients undergoing pPCI between 2009 and 2011. 
Results: A total of 1,055 patients were included, 3.3% of them ≤ 40 years. Young patients were more often 
black, smokers and with a family history of coronary artery disease, and less often hypertensive and 
dyslipidemic. In patients ≤ 40 years, leukocyte count and ultrasensitive troponin levels at admission were 
higher, and high density lipoprotein-cholesterol, lower. The left anterior descending artery as a culprit 
vessel and left ventricular ejection fraction did not differ between groups. Although the TIMI 3 flow pre-
intervention was similar, young people showed higher prevalence of myocardial blush 3 pre-procedure. 
The door-to-balloon time was lower in younger patients (1.0 hour [0.8-1.4 hour] vs. 1.3 hour [0.9-1.7 hour]; 
p = 0.03). At 30 days, patients ≤ 40 years had a mortality of 0% vs. 8.8% for patients > 40 years (p = 0.07). 
Conclusions: Patients ≤ 40 years with STEMI and undergoing pPCI show differences in clinical, angiographic 
and procedural characteristics compared to those > 40 years. In this analysis, representative of the current 
medical practice, the 30-day mortality of these patients was very low.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Published by Elsevier Editora Ltda. 
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 
 
Perfil clínico e resultados da intervenção coronária percutânea primária  
em pacientes jovens
R E S U M O
Introdução: A epidemiologia do infarto agudo do miocárdio com supradesnivelamento do segmento ST 
(IAMCST) tem se modificado nos últimos anos, com incidência maior em jovens. Nosso objetivo foi 
comparar o perfil clínico, laboratorial e angiográfico, e os desfechos clínicos em 30 dias de pacientes ≤ 40 
anos àqueles > 40 anos submetidos à intervenção coronária percutânea primária (ICPp).
Métodos: Estudo de coorte prospectivo com pacientes consecutivos submetidos à ICPp entre 2009 e 2011.
Resultados: No período, 1.055 pacientes foram incluídos, sendo identificados 3,3% com ≤ 40 anos. Pacientes 
jovens eram mais frequentemente negros, tabagistas e com história familiar de doença coronária, e menos 
frequentemente hipertensos e dislipidêmicos. Nos pacientes ≤ 40 anos, a dosagem de leucócitos e da 
troponina ultrassensível na admissão foi maior, e a lipoproteína de alta densidade-colesterol, menor. A 
artéria descendente anterior como vaso culpado e a fração de ejeção do ventrículo esquerdo não foram 
diferentes entre os grupos. Apesar de o fluxo TIMI 3 pré ser similar, os jovens mostraram maior prevalência 
de blush miocárdico 3 pré-procedimento. O tempo porta-balão foi menor nos pacientes mais jovens (1,0 
hora [0,8-1,4 hora] vs. 1,3 hora [0,9-1,7 hora]; p = 0,03). Em 30 dias, os pacientes ≤ 40 anos apresentaram 
mortalidade de 0% vs. 8,8% nos pacientes > 40 anos (p = 0,07).
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Introduction
Cardiovascular diseases are the leading cause of mortality in Bra-
zil and worldwide. Acute myocardial infarction (AMI) is the cardio-
vascular disease with greatest mortality, and its incidence in young 
patients has increased over the years.1-3 Currently, the incidence in 
patients under 40 years is around 4%-10%.4-7
In several studies, it was observed that myocardial infarction in 
young patients is most often associated with smoking, family his-
tory of coronary artery disease, and dyslipidemia.4,5,7,8 However, 
there are few Brazilian studies evaluating this question.
The objective of this study was to evaluate the clinical and angio-
graphic characteristics as well as the clinical outcome for young pa-
tients with ST-segment elevation myocardial infarction (STEMI) 




All patients diagnosed with AMI admitted to this institution from 
December 1st, 2009 to December 31st, 2011 were prospectively 
evaluated. Inclusion criteria were clinical and electrocardiographic 
diagnosis of myocardial infarction, and indication for pPCI by the at-
tending physician. Exclusion criteria were )t > 12 hours, age < 18 
years, and refusal to sign the informed consent.
STEMI was defined as the presence of a typical pain at rest associ-
ated to ST-segment elevation in two contiguous leads of at least 1 
mm in the frontal plane or 2 mm in the horizontal plane, or the pres-
ence of a typical chest pain at rest in patients with a new left bundle 
branch block.
Patients were categorized into two groups: patients aged ≤ 40 
years and controls (> 40 years). The clinical characteristics and out-
comes were compared. The study was approved by the Ethics Com-
mittee of this institution.
Percutaneous procedure
The Hemodynamics Service of this institution operates full-
time, 24 hours a day, 7 days a week. Approximately 500 pPCI proce-
dures are performed annually. The institutional routine is an 
acetylsalicylic acid loading dose of 300 mg and clopidogrel 300-
600 mg at admission to emergency department and heparin 60-
100 U/kg. pPCI procedures are performed as described in the 
literature.9 Specific technical aspects, such as access route, drug 
administration, type of stent, and thromboaspiration, are at opera-
tors’ discretion.
Clinical, laboratory, and angiographic evaluation
The clinical interview was conducted by trained researchers. De-
mographics, risk factors for ischemic heart disease, medical history, 
and clinical presentation of the event data were collected. Labora-
tory tests were conducted according to the institutional criteria and 
included, among others, serum glucose concentration, renal func-
tion, and inflammation and myocardial necrosis markers.
Angiographic evaluations were performed by a digital electronic 
system AXIOM Artis (Siemens, Munich, Germany). Target vessel ref-
erence diameter was defined as the average of proximal and distal 
diameters from the lesion, and stenosis severity was evaluated in 
two orthogonal projections; the most severe was considered, both 
before and after stent implantation. The lesion length was measured 
shoulder-to-shoulder and lesions with a normal arterial segment < 
10 mm between them were considered as a single lesion. The coro-
nary flow before and after the procedure was evaluated and de-
scribed according to Thrombolysis In Myocardial Infarction (TIMI) 
criteria. Myocardial perfusion was assessed by myocardial blush, as 
previously described.10
30-day clinical outcomes
The 30-day follow-up was conducted by phone, and occurrences 
of death, stroke, reinfarction, need for a new percutaneous or surgi-
cal revascularization, and/or stent thrombosis were registered.
Statistical analysis
SPSS version 17.0 for Windows was used for statistical analysis. 
Continuous variables were presented as mean and standard devia-
tion, and compared using Student’s t-test. Continuous variables 
with non-normal distribution were described as median and inter-
quartile range and compared using the Mann-Whitney test. Cate-
gorical variables were described as absolute number and percentage 
and compared by the Chi-squared test or Fisher’s exact test, as ap-
propriate. Statistical significance was defined by a two-tailed 
p-value < 0.05.
Results
During the study period, 1,055 patients were included, of whom 
35 (3.3%) were aged ≤ 40 years. The mean age of young patients was 
34.1 ± 4.5 years and 61.3 ± 11.1 years for those aged > 40 years. 
Table 1 shows the clinical characteristics of both groups. African de-
scent, smoking, and family history of premature coronary artery 
disease were more frequent among patients ≤ 40 years. On the con-
trary, younger patients were less frequently affected by hyperten-
sion or dyslipidemia, and this group had lower rates of previous 
percutaneous revascularization. The prevalence of diabetes mellitus 
was similar. The door-to-balloon time was lower in patients aged 
≤ 40 years (1.0 h [0.8-1.4 h] vs. 1.3 h [0.9–1.7 h]; p = 0.03).
Table 2 describes laboratory characteristics of each group. In pa-
tients aged ≤ 40 years, the leukocyte count and ultrasensitive tropo-
nin level at admission were higher, and the high-density lipoprotein 
cholesterol (HDL-C) level was lower. There was no significant differ-
ence in other markers of myocardial necrosis or inf lammation 
between groups.
Table 3 shows angiographic and procedural characteristics; 
note that three-vessel involvement, left anterior descending artery 
as the culprit vessel, and left ventricular ejection fraction did not 
differ between groups. Although there was equivalence of pre-pro-
cedural TIMI-3 flows, the younger group had a higher prevalence of 
grade 3 myocardial blush before the procedure. The reference di-
ameter was similar, but younger patients showed shorter lesions. 
Conclusões: Pacientes ≤ 40 anos com IAMCST e submetidos à ICPp apresentam diferenças nos perfis clínico, 
angiográfico e do procedimento quando comparados àqueles > 40 anos. Nesta análise, representativa da 
prática médica atual, a mortalidade em 30 dias desses pacientes foi muito baixa.
© 2015 Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. Publicado por Elsevier Editora Ltda. 
Este é um artigo Open Access sob a licença de CC BY-NC-ND (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The use of glycoprotein IIb/IIIa inhibitors was higher among young 
patients.
During hospitalization, there were no differences between 
groups as to the need for mechanical ventilation (8.6% vs. 9.3%; p = 
0.98), acute renal failure (5.7% vs. 4.1%, p = 0.54), or sepsis (2.9% vs. 
3.6%, p = 0.88). In patients aged ≤ 40 years, no clinical events, except 
for reinfarction (2.9% vs. 5.1%, p = 0.61), occurred in the first 30 days 
(Table 4).
Discussion
This study analyzed the clinical and angiographic profiles and 
clinical outcomes of patients ≤ 40 years of age who had STEMI in a 
tertiary cardiology center. Among younger patients, African descent, 
smoking, and family history of ischemic heart disease were more 
frequent, but no difference for diabetes mellitus frequency was 
noted. Younger patients had other comorbidities and multivessel 
disease less often and there was a trend for a better clinical outcome 
after 30 days in this group. In Brazil, contemporary studies analyzing 
the clinical characteristics of young patients with AMI are few,1,2,11 
and it is believed that the data presented here can contribute to the 
development of public health policies and prevention campaigns.
This study showed high prevalence of smoking in younger pa-
tients with AMI (around 70%), which is consistent with reports from 
other studies that included patients with the same age group. This 
association has been identified in most published studies, with a 
prevalence of 65% to 95%.5,12-18 Smoking plays an important role in 
the genesis, progression and destabilization of atherosclerotic 
plaques, and its specific association with younger patients is impor-
tant and deserves further evaluation.
A significantly higher frequency of a positive family history of 
ischemic heart disease in young patients analyzed in this study repre-
sents another important aspect. Family history is also a classic risk 
factor for ischemic heart disease, and the data presented in this study 
are also consistent with other reports in the literature.19-21 The influ-
ence of a genetic factor and its greater association in this age group 
are other important aspects, considering the pathophysiology and 
possible predisposing factors for AMI in patients ≤ 40 years of age.
Among younger patients, African descent was more frequent vs. 
patients over 40 years. This finding has not been described in previ-
ous studies evaluating patients with STEMI in this age group. The 
influence of genetic traits or associations among socioeconomic and 
cultural factors, the adherence to medications, and lifestyle could 
explain these findings, and deserve to be better evaluated in Brazil-
ian populations.
The diagnosis of dyslipidemia was less common in younger pa-
tients, but they had lower HDL-C levels vs. older patients. Kaukola et 
al.22 also showed similar values for total cholesterol in younger pa-
tients and in those over 40 years, but with HDL values slightly lower 
in younger patients, with a slightly higher triglyceride level in this 
group. A low level of HDL has been associated with acute myocardial 
infarction in young patients.23 Some studies indicated only high cho-
lesterol level as a risk factor,5,17,24,25 but the establishment of an asso-





≤ 40 years  
(n = 35)




Female, n (%) 12 (34.3) 330 (32.4) 0.57
African descent, n (%) 7 (20.0) 87 (8.5) 0.02
Hypertension, n (%) 9 (25.7) 700 (68.6) < 0.01
Dyslipidemia, n (%) 6 (17.1) 369 (36.2) 0.04
Currently smoking, n (%) 24 (68.6) 447 (43.8) < 0.01
Diabetes mellitus, n (%) 7 (20.0) 235 (23.0) 0.90
Family history of CAD, n (%) 18 (51.4) 336 (32.9) < 0.01
Prior angina, n (%) 8 (22.9) 422 (41.4) 0.07
Previous myocardial infarction, n (%) 3 (8.6) 219 (21.5) 0.18
Previous stroke, n (%) 0 (0) 68 (6.7) 0.13
Prior PCI, n (%) 1 (2.9) 165 (16.2) 0.05
Prior CABG, n (%) 0 (0) 45 (4.4) 0.23
Chronic renal failure, n (%) 0 (0) 31 (3.0) 0.32
Anterior myocardial infarction, n (%) 17 (48.6) 460 (45.1) 0.40
Chronic use of ASA, n (%) 2 (5.7) 299 (29.3) < 0.01
Creatinine clearance, mL/min 125.4 ± 40.4 81.5 ± 33.2 < 0.01
BMI, kg/m2 27.8 ± 4.8 26.9 ± 4.25 0.31
Waist circumference, cm 94.3 ± 12.9 94.7 ± 14.3 0.86
Systolic blood pressure, mmHg 131.0 ± 27.8 134.8 ± 30.4 0.46
Diastolic blood pressure, mmHg 78.8 ± 14.0 81.9 ± 18.5 0.33
Heart rate, beats/minute 81.4 ± 16.1 78.9 ± 20.0 0.48
Delta t, h 4.0 (2.5–6.4) 3.5 (1.6–6) 0.27
Door-to-balloon time, h 1.0 (0.8–1.4) 1.3 (0.9– 1.7) 0.03
CAD: coronary artery disease; PCI: percutaneous coronary intervention; CABG: coronary artery by-




≤ 40 year 
(n = 35)
> 40 year
(n = 1,020) p-value
Total cholesterol, mg/dL 204.5 ± 60.8 202.1 ± 49.1 0.80
HDL-C, mg/dL 35.6 ± 14.3 40.7 ± 11.6 0.03
Triglycerides, mg/dL 120.0 (91.0- 259.5) 114.0 (75.0-177.0) 0.16
Creatinine, mg/dL 0.85 (0.7-1.1) 0.95 (0.8-1.1) 0.06
Blood glucose, mg/dL 124.5 (111.5-177.5) 143.0 (119.0-184.0) 0.11
Hematocrit, % 41.0 ± 4.3 40.6 ± 4.8 0.64
Hemoglobin, g/dL 13.9 ± 1.4 13.6 ± 1.7 0.35
Platelets, mm³ 290,840.0 ± 127,872.2 250,909 ± 75,569.3 0.13
Leukocytes, mm³ 16.018.1± 6.493.0 12,708.2 ± 4,355.4 < 0.01
Potassium, mEq/L 4.6 ± 0.9 4.3 ± 0.6 0.08
CRP, mg/dL 0.7 (0.26- 1.09) 0.45 (0.21-1.0) 0.20
Fibrinogen, mg/dL 239.2 ± 71.4 243.7 ± 83.9 0.81
CK, U/L 258 (79-550) 130 (57-408) 0.06
CK-MB ng/dL 18 (5-45) 11 (6- 30) 0.58
Troponin, ng/mL 0.30 (0.5-2.4) 0.40 (0.4-2.0) 0.93
US troponin, ng/dL 1,424 (109-8,480) 215 (46-1,103) 0.02
HDL-C: high-density lipoprotein cholesterol; CRP: C-reactive protein; CK: creatine phosphokinase; 
CK-MB: creatine kinase-MB isoenzyme; US: ultrasensitive.
Table 3
Angiographic and procedural characteristics.
Characteristic
≤ 40 years  
(n = 35)
> 40 years  
(n = 1,020) p-value
LAD lesion, n (%) 16 (45.7) 444 (43.5) 0.26
Three-vessel lesion, n (%) 4 (11.4) 193 (18.9) 0.40
Ejection fraction, % 59.6 ± 9.3 55.8 ± 11.6 0.48
TIMI 3 flow, n (%) 
Pre-procedural 8 (22.9) 226 (22.2) 0.52
Post-procedural 27 (77.1) 903 (88.5) 0.07
Blush grade 3, n (%) 
Pre-procedural 8 (22.9) 142 (13.9) 0.04
Post-procedural 18 (51.4) 682 (66.9) 0.91
Reference diameter, mm 3.2 ± 0.6 3.1 ± 0.4 0.61
Pre-procedural diameter stenosis, % 92.5 ± 20.2 97.3 ± 7.4 0.21
Lesion length, mm 14.8 ± 3.8 17.8 ± 8.6 < 0.01
Thromboaspiration, n (%) 13 (37.1) 369 (36.2) 0.31
Glycoprotein IIb/IIIa, n (%) 13 (37.1) 285 (27.9) 0.03
Stent diameter, mm 3.2 ± 0.5 3.1 ± 0.4 0.49
Stent length, mm 18.2 ± 4.7 19.8 ± 6.5 0.12
Deployment pressure, atm 13.8 ± 2.3 14.2 ± 2.5 0.46
Post-procedural diameter stenosis, % 0.0 ± 0.0 4.5 ± 18.3 < 0.01
LAD: left anterior descendent coronary.
Table 4
Clinical outcomes in 30 days.
Characteristic
≤ 40 years  
(n = 35)
> 40 years  
(n = 1,020) p-value
Death, n (%) 0 (0) 95 (9.3) 0.07
Stroke, n (%) 0 (0) 9 (0.8) 0.59
Reinfarction, n (%) 1 (2.9) 52 (5.1) 0.61
Urgent CABG, n (%) 0 (0) 6 (0.6) 0.66
Stent thrombosis, n (%) 0 (0) 28 (2.7) 0.34
CABG: coronary artery bypass graft. 
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diseases in this age group. An association between dyslipidemia and 
AMI at an early age has been documented in other studies.12
In the present study, the early clinical outcome of younger pa-
tients was better vs. patients over 40 years, although without statis-
tical significance. These findings are also consistent with most 
studies, which pointed to a lower incidence of adverse outcomes in 
young patients, and this could be due to a better capacity for regen-
eration and of response to injury and to a lower association with co-
morbidities.4,5,8
Conclusions
The frequency of acute myocardial infarction with ST-segment 
elevation in patients ≤ 40 years of age is small, but these patients have 
different clinical and laboratory characteristics and early clinical out-
comes vs. older patients. Population studies, with larger numbers of 
patients in Brazil, are important for a better understanding of this 
problem, as well as to guide prevention and public health campaigns.
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